Rafeifadattis, K. F. (2025) “Empaglifozin In Type 2 Diabetes: From Mechanisms To Clinical Practice – A Comprehensive Review Of Monotherapy, Combinations, And Therapeutic Advantages”, Jurnal Ners, 10(1), pp. 182–195. doi: 10.31004/jn.v10i1.51869.